Moderna, Merck shares fall on eagerly anticipated cancer vaccine results

The Quick Take
Moderna, Merck shares fall on eagerly anticipated cancer vaccine results BioPharma Dive Moderna’s Stock Plummets After Cancer-Vaccine Data Shared on Social Media WSJ A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42% Time Magazine Moderna shares plunge after leak of cancer vaccine data despite positive results CNBC Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna
Ground Level News gathers headlines from public news feeds. This page shows a short summary only; the full article and all rights belong to BioPharma Dive.



